Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - COST OF REVENUE
Cost of Revenue HRTX - Heron Therapeutics, Inc.
65.1 M
LAST VALUE
18.94%
2 YEAR CAGR
18.80%
5 YEAR CAGR
7.73%
10 YEAR CAGR